v3.26.1
Income Taxes - Deferred Income Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Deferred tax assets:    
Net operating loss carry forward $ 354,545 $ 246,178
Capital Loss 2,092 0
Tax credits 30,765 29,595
Accruals and reserves 2,505 881
Stock-based compensation expense 2,520 6,134
Lease liability (ASC 842) 4,057 8,666
Section 174 R&D capitalization 64,179 101,876
Inventory reserves 21,279 9,113
Depreciation and amortization 18,138 15,380
Basis difference on debt obligation 20,237 9,692
Deferred interest expense 9,097 3,698
Unrealized Gain 3,546 3,451
Other 0 515
Total deferred tax assets 532,960 435,179
Valuation allowance (528,953) (427,222)
Total deferred tax asset 4,007 7,957
Deferred tax liabilities:    
Other 378 0
ROU asset (ASC 842) 3,629 7,957
Total deferred tax liabilities 4,007 7,957
Net deferred tax assets (liabilities) 0 0
Valuation allowance 528,953 427,222
United States [Member]    
Deferred tax assets:    
Valuation allowance (529,000) (427,200)
Deferred tax liabilities:    
Valuation allowance 529,000 $ 427,200
Valuation allowance, increase (decrease), amount 101,700  
Net operating loss carryforwards 1,300,000  
Net operating loss carryforwards, not subject to expiration 1,200,000  
United States [Member] | Research Tax Credit Carryforward [Member]    
Deferred tax liabilities:    
Research and development tax credit carryforwards $ 31,200  
U.S. State [Member]    
Deferred tax liabilities:    
Expiration date Dec. 31, 2035  
Research and development tax credit carryforwards $ 1,200,000  
Expiration Date Dec. 31, 2028  
U.S. State [Member] | Research Tax Credit Carryforward [Member]    
Deferred tax liabilities:    
Research and development tax credit carryforwards $ 7,300